The purpose of this PQI is to understand the management techniques and interventions related to the utilization of the combination treatment of enfortumab vedotin-ejfv and pembrolizumab.
Enfortumab Vedotin-ejfv (Padcev) and Pembrolizumab (Keytruda) Management for Advanced or Metastatic Urothelial Carcinoma
Download PQI pdf 0.26MB
Last Updated: July 29, 2025
More About This PQI
PQI:
PQI in Action Articles:
PQI in Action Articles:
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQI